The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy

Sylvain Goutelle 1 Laurent Bourguignon 1 P. Maire R. W. Jelliffe M. Neely
1 Evaluation et modélisation des effets thérapeutiques
Département biostatistiques et modélisation pour la santé et l'environnement [LBBE]
Document type :
Journal articles
Complete list of metadatas
https://hal-univ-lyon1.archives-ouvertes.fr/hal-02046812
Contributor : Christelle Cheval <>
Submitted on : Friday, February 22, 2019 - 7:05:02 PM
Last modification on : Monday, February 10, 2020 - 4:36:58 PM

Identifiers

  • HAL Id : hal-02046812, version 1

Collections

UNIV-LYON1 | CNRS | BIOENVIS | INRIA | UDL

Citation

Sylvain Goutelle, Laurent Bourguignon, P. Maire, R. W. Jelliffe, M. Neely. The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy. Current Pharmaceutical Design, 2014, 20, pp.6191-6206. ⟨hal-02046812⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

23

Contact

Informations

CCSD